Jean‐Yves Douillard

Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5‐fluorouracil‐based therapy together with cetuximab–irinotecan

Marie-Christine Étienne-Grimaldi, Jaafar Bennouna, Jean‐Louis Formento et al. · British Journal of Clinical Pharmacology · 2011 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Panitumumab‐based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials

Dominik Paul Modest, Fernando Rivera, Jean‐Baptiste Bachet et al. · International Journal of Cancer · 2019 · 32 citations · Full text

Medicine, Oncology, Pharmacology +12

Subcutaneous interleukin‐2 and interferon α in the treatment of patients with metastatic renal cell carcinoma—Less efficacy compared with intravenous interleukin‐2 and interferon α

Alain Ravaud, R. Delva, Frédéríc Gomez et al. · Cancer · 2002 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Characterization, isolation and amino terminal sequencing of a rat colon carcinoma‐associated antigen

Corinne Chadéneau, Marc G. Denis, Hervé M. Blottière et al. · International Journal of Cancer · 1991 · 16 citations

Medicine, Molecular Biology, Oncology +17